Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Some very early research into a nontraditional target holds promise for a new line of defense against HIV in decades to come. New compounds that are tentatively being called maturation or assembly inhibitors provide a very early target in HIV’s activity within the body, researchers say.

Assembly inhibitors offer hope for future treatment